Erythroderma in children is an uncommon, yet striking entity with an incidence of 0.11%. Psoriatic erythroderma accounts for 1.4% of psoriasis cases in children. Follicular psoriasis is an underdiagnosed variant of psoriasis, with only about 15 cases reported till date, characterized by scaly follicular papules on the trunk and extremities. Although two thirds of these reported occurred in adults, cases have been described in children under the age of 10 years. Follicular lesions may present without psoriasis vulgaris elsewhere. We report here a 13-year-old boy who presented with severe erythrodermic psoriasis that started as dark, rough, horny, discrete, follicular papules over knees and elbows, associated with nail and joint involvement. Such a presentation of follicular psoriasis causing erythroderma is uncommonly seen in children and has not yet been reported in literature.

No abstract

Keratoacanthoma centrifugam marginatum (KCM) is a rare variant of keratoacanthoma characterized by a progressive peripheral growth with concomitant central healing. We report a case of a 50-year-old female who presented with multiple, veracious non-tender papules coalescing to form multiple plaques of varied diameter perioral, which was gradually progressive. On the basis of history, clinical presentation and histopathology, diagnosis of KCM was confirmed. We report this case because of atypical presentation and clinical rarity.

No abstract

<p>In the beginning of the COVID-19 pandemic when we were still getting used to the rising cases every day and limited resources to deal them with, the focus was to get a hold of the situation as quickly as possible. Seven months into the pandemic, the cases are still on the rise but we have gathered some knowledge through the researches getting published every day, most of which are focused on the involvement of respiratory system, cardiovascular system, central nervous system, and gastrointestinal system. Dermatological manifestations have not been given their due importance. Lately, many patients have started presenting with dermatological manifestation sometimes preceding or sometimes during COVID-19 infection with or without involvement of other systems. This may be beneficial to clinicians all over the world, to determine potential dermatological signs in COVID-19 and also help in earlier suspection of the COVID-19 infection. Many cutaneous adverse drug reactions (ADR) to drugs advocated in COVID-19 treatment are also being reported every day, which are discussed in this review.</p><p>Here we attempt to review dermatological manifestations of COVID-19 infections and drug reactions by the drugs advocated for its treatment and an understanding in its path mechanisms reported thus far. This will help clinicians to get an insight into what to expect and when to expect in terms of dermatological manifestation of COVID-19 and its drugs.</p>